The multifaceted role of the inflammasome in inflammatory bowel diseases

TheScientificWorldJournal

Volumn 11, Issue , 2011, Pages 1536-1547

  Lissner, Donata ^a   Siegmund, Britta ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cytokines; Inflammasome; Inflammatory bowel diseases

Indexed keywords

CRYOPYRIN; DEXTRAN SULFATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 18; TOLL LIKE RECEPTOR; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADAPTIVE IMMUNITY; ADENOVIRUS; AUTOIMMUNE DISEASE; BEHCET DISEASE; CANDIDA ALBICANS; CINCA SYNDROME; CROHN DISEASE; DENDRITIC CELL; DISEASE PREDISPOSITION; ENTERITIS; ENZYME ACTIVATION; EPITHELIUM; FAMILIAL COLD AUTOINFLAMMATORY SYNDROME; FAMILIAL MEDITERRANEAN FEVER; GENE MUTATION; HYPERIMMUNOGLOBULINEMIA D AND PERIODIC FEVER SYNDROME; IN VIVO STUDY; INFLUENZA VIRUS; INTESTINE EPITHELIUM CELL; JUVENILE STILL DISEASE; KNOCKOUT MOUSE; LAMINA PROPRIA; LISTERIA MONOCYTOGENES; MACROPHAGE; MUCKLE WELLS SYNDROME; NONHUMAN; PATHOGENESIS; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; SACCHAROMYCES CEREVISIAE; SINGLE NUCLEOTIDE POLYMORPHISM; STAPHYLOCOCCUS AUREUS;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMASOMES; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-18; INTERLEUKIN-1BETA; INTESTINES; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL;

EID: 84860416606     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2011.139     Document Type: Review

References (81)

1. Dinarello, C.A. (2002) The IL-1 family and inflammatory diseases. Clin. Exp. Rheumatol. 20, S1-13.
2. Guarda, G. and So, A. (2010) Regulation of inflammasome activity. Immunology 130, 329-336.
3. Franchi, L., Eigenbrod, T., Munoz-Planillo, R., and Nunez, G. (2009) The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat. Immunol. 10, 241-247.
4. Dinarello, C.A. (2010) IL-1: discoveries, controversies and future directions. Eur. J. Immunol. 40, 599-606.
5. Dinarello, C.A., Renfer, L., and Wolff, S.M. (1977) Human leukocytic pyrogen: purification and development of a radioimmunoassay. Proc. Natl. Acad. Sci. U. S. A. 74, 4624-4627.
6. Auron, P.E., Webb, A.C., Rosenwasser, L.J., Mucci, S.F., Rich, A., Wolff, S.M., and Dinarello, C.A. (1984) Nucleotide sequence of human monocyte interleukin 1 precursor cDNA. Proc. Natl. Acad. Sci. U. S. A. 81, 7907-7911.
7. Thornberry, N.A., Bull, H.G., Calaycay, J.R., Chapman, K.T., Howard, A.D., Kostura, M.J., Miller, D.K., Molineaux, S.M., Weidner, J.R., Aunins, J., et al. (1992) A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 356, 768-774.
8. Martinon, F., Burns, K., and Tschopp, J. (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell 10, 417-426.
9. Agostini, L., Martinon, F., Burns, K., McDermott, M.F., Hawkins, P.N., and Tschopp, J. (2004) NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 20, 319-325.
10. Mariathasan, S., Newton, K., Monack, D.M., Vucic, D., French, D.M., Lee, W.P., Roose-Girma, M., Erickson, S., and Dixit, V.M. (2004) Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430, 213-218.
11. Feldmeyer, L., Keller, M., Niklaus, G., Hohl, D., Werner, S., and Beer, H.D. (2007) The inflammasome mediates UVB-induced activation and secretion of interleukin-1beta by keratinocytes. Curr. Biol. 17, 1140-1145.
12. Abdul-Sater, A.A., Koo, E., Hacker, G., and Ojcius, D.M. (2009) Inflammasome-dependent caspase-1 activation in cervical epithelial cells stimulates growth of the intracellular pathogen Chlamydia trachomatis. J. Biol. Chem. 284, 26789-26796.
13. Yilmaz, O., Sater, A.A., Yao, L., Koutouzis, T., Pettengill, M., and Ojcius, D.M. (2010) ATP-dependent activation of an inflammasome in primary gingival epithelial cells infected by Porphyromonas gingivalis. Cell. Microbiol. 12, 188-198.
14. Zaki, M.H., Boyd, K.L., Vogel, P., Kastan, M.B., Lamkanfi, M., and Kanneganti, T.D. (2010) The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 32, 379-391.
15. Stienstra, R., Joosten, L.A., Koenen, T., van Tits, B., van Diepen, J.A., van den Berg, S.A., Rensen, P.C., Voshol, P.J., Fantuzzi, G., Hijmans, A., Kersten, S., Muller, M., van den Berg, W.B., van Rooijen, N., Wabitsch, M., Kullberg, B.J., van der Meer, J.W., Kanneganti, T., Tack, C.J., and Netea, M.G. (2010) The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell Metab. 12, 593-605.
16. Bryan, N.B., Dorfleutner, A., Kramer, S.J., Yun, C., Rojanasakul, Y., and Stehlik, C. (2010) Differential splicing of the apoptosis-associated speck like protein containing a caspase recruitment domain (ASC) regulates inflammasomes. J. Inflamm. (Lond.) 7, 23.
17. Yazdi, A.S., Guarda, G., D'Ombrain, M.C., and Drexler, S.K. (2010) Inflammatory caspases in innate immunity and inflammation. J. Innate Immun. 2, 228-237.
18. Kahlenberg, J.M. and Dubyak, G.R. (2004) Mechanisms of caspase-1 activation by P2X7 receptor-mediated K+ release. Am. J. Physiol. Cell Physiol. 286, C1100-1108.
19. Kanneganti, T.D., Lamkanfi, M., Kim, Y.G., Chen, G., Park, J.H., Franchi, L., Vandenabeele, P., and Nunez, G. (2007) Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling. Immunity 26, 433-443.
20. Hornung, V., Bauernfeind, F., Halle, A., Samstad, E.O., Kono, H., Rock, K.L., Fitzgerald, K.A., and Latz, E. (2008) Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 9, 847-856.
21. Cruz, C.M., Rinna, A., Forman, H.J., Ventura, A.L., Persechini, P.M., and Ojcius, D.M. (2007) ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages. J. Biol. Chem. 282, 2871-2879.
22. Zhou, R., Tardivel, A., Thorens, B., Choi, I., and Tschopp, J. (2010) Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 11, 136-140.
23. Gross, O., Poeck, H., Bscheider, M., Dostert, C., Hannesschlager, N., Endres, S., Hartmann, G., Tardivel, A., Schweighoffer, E., Tybulewicz, V., Mocsai, A., Tschopp, J., and Ruland, J. (2009) Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature 459, 433-436.
24. Mariathasan, S., Weiss, D.S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W.P., Weinrauch, Y., Monack, D.M., and Dixit, V.M. (2006) Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440, 228-232.
25. Kanneganti, T.D., Body-Malapel, M., Amer, A., Park, J.H., Whitfield, J., Franchi, L., Taraporewala, Z.F., Miller, D., Patton, J.T., Inohara, N., and Nunez, G. (2006) Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA. J. Biol. Chem. 281, 36560-36568.
26. Muruve, D.A., Petrilli, V., Zaiss, A.K., White, L.R., Clark, S.A., Ross, P.J., Parks, R.J., and Tschopp, J. (2008) The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 452, 103-107.
27. Cassel, S.L., Eisenbarth, S.C., Iyer, S.S., Sadler, J.J., Colegio, O.R., Tephly, L.A., Carter, A.B., Rothman, P.B., Flavell, R.A., and Sutterwala, F.S. (2008) The Nalp3 inflammasome is essential for the development of silicosis. Proc. Natl. Acad. Sci. U. S. A. 105, 9035-9040.
28. Dostert, C., Petrilli, V., Van Bruggen, R., Steele, C., Mossman, B.T., and Tschopp, J. (2008) Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320, 674-677.
29. Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller-Jemelka, H.I., Spinas, G.A., Kaiser, N., Halban, P.A., and Donath, M.Y. (2002) Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J. Clin. Invest. 110, 851-860.
30. Joosten, L.A., Netea, M.G., Mylona, E., Koenders, M.I., Malireddi, R.K., Oosting, M., Stienstra, R., van de Veerdonk, F.L., Stalenhoef, A.F., Giamarellos-Bourboulis, E.J., Kanneganti, T.D., and van der Meer, J.W. (2010) Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1beta production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis. Arthritis Rheum. 62, 3237-3248.
31. Yu, J.R. and Leslie, K.S. (2011) Cryopyrin-associated periodic syndrome: an update on diagnosis and treatment response. Curr. Allergy Asthma Rep. 11, 12-20.
32. Hoffman, H.M., Rosengren, S., Boyle, D.L., Cho, J.Y., Nayar, J., Mueller, J.L., Anderson, J.P., Wanderer, A.A., and Firestein, G.S. (2004) Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet 364, 1779-1785.
33. Goldbach-Mansky, R., Dailey, N.J., Canna, S.W., Gelabert, A., Jones, J., Rubin, B.I., Kim, H.J., Brewer, C., Zalewski, C., Wiggs, E., Hill, S., Turner, M.L., Karp, B.I., Aksentijevich, I., Pucino, F., Penzak, S.R., Haverkamp, M.H., Stein, L., Adams, B.S., Moore, T.L., Fuhlbrigge, R.C., Shaham, B., Jarvis, J.N., O'Neil, K., Vehe, R.K., Beitz, L.O., Gardner, G., Hannan, W.P., Warren, R.W., Horn, W., Cole, J.L., Paul, S.M., Hawkins, P.N., Pham, T.H., Snyder, C., Wesley, R.A., Hoffmann, S.C., Holland, S.M., Butman, J.A., and Kastner, D.L. (2006) Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N. Engl. J. Med. 355, 581-592.
34. Cascavilla, N., Bisceglia, M., and D'Arena, G. (2010) Successful treatment of Schnitzler's syndrome with anakinra after failure of rituximab trial. Int. J. Immunopathol. Pharmacol. 23, 633-636.
35. Lahiri, M. and Teng, G.G. (2010) A case of refractory adult-onset Still's disease treated with anakinra. Int. J. Rheum. Dis. 13, e36-41.
36. Gattorno, M., Piccini, A., Lasiglie, D., Tassi, S., Brisca, G., Carta, S., Delfino, L., Ferlito, F., Pelagatti, M.A., Caroli, F., Buoncompagni, A., Viola, S., Loy, A., Sironi, M., Vecchi, A., Ravelli, A., Martini, A., and Rubartelli, A. (2008) The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 58, 1505-1515.
37. Kastbom, A., Verma, D., Eriksson, P., Skogh, T., Wingren, G., and Soderkvist, P. (2008) Genetic variation in proteins of the cryopyrin inflammasome influences susceptibility and severity of rheumatoid arthritis (the Swedish TIRA project). Rheumatology (Oxford) 47, 415-417.
38. Jiang, Y., Genant, H.K., Watt, I., Cobby, M., Bresnihan, B., Aitchison, R., and McCabe, D. (2000) A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores. Arthritis Rheum. 43, 1001-1009.
39. Genant, H.K. (2001) Interleukin-1 receptor antagonist treatment of rheumatoid arthritis patients: radiologic progression and correlation of Genant/Sharp and Larsen scoring methods. Semin. Arthritis Rheum. 30, 26-32.
40. Schroder, K., Zhou, R., and Tschopp, J. (2010) The NLRP3 inflammasome: a sensor for metabolic danger? Science 327, 296-300.
41. Larsen, C.M., Faulenbach, M., Vaag, A., Volund, A., Ehses, J.A., Seifert, B., Mandrup-Poulsen, T., and Donath, M.Y. (2007) Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N. Engl. J. Med. 356, 1517-1526.
42. So, A., De Smedt, T., Revaz, S., and Tschopp, J. (2007) A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res. Ther. 9, R28.
43. Singh, D. and Huston, K.K. (2009) IL-1 inhibition with anakinra in a patient with refractory gout. J. Clin. Rheumatol. 15, 366.
44. Villani, A.C., Lemire, M., Fortin, G., Louis, E., Silverberg, M.S., Collette, C., Baba, N., Libioulle, C., Belaiche, J., Bitton, A., Gaudet, D., Cohen, A., Langelier, D., Fortin, P.R., Wither, J.E., Sarfati, M., Rutgeerts, P., Rioux, J.D., Vermeire, S., Hudson, T.J., and Franchimont, D. (2009) Common variants in the NLRP3 region contribute to Crohn's disease susceptibility. Nat. Genet. 41, 71-76.
45. Schoultz, I., Verma, D., Halfvarsson, J., Torkvist, L., Fredrikson, M., Sjoqvist, U., Lordal, M., Tysk, C., Lerm, M., Soderkvist, P., and Soderholm, J.D. (2009) Combined polymorphisms in genes encoding the inflammasome components NALP3 and CARD8 confer susceptibility to Crohn's disease in Swedish men. Am. J. Gastroenterol. 104, 1180-1188.
46. Lewis, G.J., Massey, D.C., Zhang, H., Bredin, F., Tremelling, M., Lee, J.C., Berzuini, C., and Parkes, M. (2011) Genetic association between NLRP3 variants and Crohn's disease does not replicate in a large UK panel. Inflamm. Bowel Dis. 17, 1387-1391.
47. Tamura, K., Fukuda, Y., Sashio, H., Takeda, N., Bamba, H., Kosaka, T., Fukui, S., Sawada, K., Satomi, M., Yamada, T., Yamamura, T., Yamamoto, Y., Furuyama, J., Okamura, H., and Shimoyama, T. (2002) IL18 polymorphism is associated with an increased risk of Crohn's disease. J. Gastroenterol. 37(Suppl 14), 111-116.
48. Zhernakova, A., Festen, E.M., Franke, L., Trynka, G., van Diemen, C.C., Monsuur, A.J., Bevova, M., Nijmeijer, R.M., van 't Slot, R., Heijmans, R., Boezen, H.M., van Heel, D.A., van Bodegraven, A.A., Stokkers, P.C., Wijmenga, C., Crusius, J.B., and Weersma, R.K. (2008) Genetic analysis of innate immunity in Crohn's disease and ulcerative colitis identifies two susceptibility loci harboring CARD9 and IL18RAP. Am. J. Hum. Genet. 82, 1202-1210.
49. Ogura, Y., Bonen, D.K., Inohara, N., Nicolae, D.L., Chen, F.F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R.H., Achkar, J.P., Brant, S.R., Bayless, T.M., Kirschner, B.S., Hanauer, S.B., Nunez, G., and Cho, J.H. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411, 603-606.
50. Siegmund, B. and Zeitz, M. (2009) Clinical aspects of inflammatory bowel disease. Eur. J. Immunol. 39, 2026-2030.
51. Mahida, Y.R., Wu, K., and Jewell, D.P. (1989) Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease. Gut 30, 835-838.
52. Pizarro, T.T., Michie, M.H., Bentz, M., Woraratanadharm, J., Smith, M.F., Jr., Foley, E., Moskaluk, C.A., Bickston, S.J., and Cominelli, F. (1999) IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells. J. Immunol. 162, 6829-6835.
53. Monteleone, G., Trapasso, F., Parrello, T., Biancone, L., Stella, A., Iuliano, R., Luzza, F., Fusco, A., and Pallone, F. (1999) Bioactive IL-18 expression is up-regulated in Crohn's disease. J. Immunol. 163, 143-147.
54. Al-Sadi, R.M. and Ma, T.Y. (2007) IL-1beta causes an increase in intestinal epithelial tight junction permeability. J. Immunol. 178, 4641-4649.
55. Cominelli, F., Nast, C.C., Duchini, A., and Lee, M. (1992) Recombinant interleukin-1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in rabbit immune colitis. Gastroenterology 103, 65-71.
56. Ferretti, M., Casini-Raggi, V., Pizarro, T.T., Eisenberg, S.P., Nast, C.C., and Cominelli, F. (1994) Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis. J. Clin. Invest. 94, 449-453.
57. Kanai, T., Watanabe, M., Okazawa, A., Sato, T., Yamazaki, M., Okamoto, S., Ishii, H., Totsuka, T., Iiyama, R., Okamoto, R., Ikeda, M., Kurimoto, M., Takeda, K., Akira, S., and Hibi, T. (2001) Macrophage-derived IL-18-mediated intestinal inflammation in the murine model of Crohn's disease. Gastroenterology 121, 875-888.
58. Siegmund, B., Fantuzzi, G., Rieder, F., Gamboni-Robertson, F., Lehr, H.A., Hartmann, G., Dinarello, C.A., Endres, S., and Eigler, A. (2001) Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281, R1264-1273.
59. Sivakumar, P.V., Westrich, G.M., Kanaly, S., Garka, K., Born, T.L., Derry, J.M., and Viney, J.L. (2002) Interleukin 18 is a primary mediator of the inflammation associated with dextran sulphate sodium induced colitis: blocking interleukin 18 attenuates intestinal damage. Gut 50, 812-820.
60. Siegmund, B., Lehr, H.A., Fantuzzi, G., and Dinarello, C.A. (2001) IL-1 beta -converting enzyme (caspase-1) in intestinal inflammation. Proc. Natl. Acad. Sci. U. S. A. 98, 13249-13254.
61. Loher, F., Bauer, C., Landauer, N., Schmall, K., Siegmund, B., Lehr, H.A., Dauer, M., Schoenharting, M., Endres, S., and Eigler, A. (2004) The interleukin-1 beta-converting enzyme inhibitor pralnacasan reduces dextran sulfate sodium-induced murine colitis and T helper 1 T-cell activation. J. Pharmacol. Exp. Ther. 308, 583-590.
62. Bauer, C., Loher, F., Dauer, M., Mayer, C., Lehr, H.A., Schonharting, M., Hallwachs, R., Endres, S., and Eigler, A. (2007) The ICE inhibitor pralnacasan prevents DSS-induced colitis in C57BL/6 mice and suppresses IP-10 mRNA but not TNF-alpha mRNA expression. Dig. Dis. Sci. 52, 1642-1652.
63. Wirtz, S., Becker, C., Blumberg, R., Galle, P.R., and Neurath, M.F. (2002) Treatment of T cell-dependent experimental colitis in SCID mice by local administration of an adenovirus expressing IL-18 antisense mRNA. J. Immunol. 168, 411-420.
64. Takagi, H., Kanai, T., Okazawa, A., Kishi, Y., Sato, T., Takaishi, H., Inoue, N., Ogata, H., Iwao, Y., Hoshino, K., Takeda, K., Akira, S., Watanabe, M., Ishii, H., and Hibi, T. (2003) Contrasting action of IL-12 and IL-18 in the development of dextran sodium sulphate colitis in mice. Scand. J. Gastroenterol. 38, 837-844.
65. Lebeis, S.L., Powell, K.R., Merlin, D., Sherman, M.A., and Kalman, D. (2009) Interleukin-1 receptor signaling protects mice from lethal intestinal damage caused by the attaching and effacing pathogen Citrobacter rodentium. Infect. Immun. 77, 604-614.
66. Allen, I.C., TeKippe, E.M., Woodford, R.M., Uronis, J.M., Holl, E.K., Rogers, A.B., Herfarth, H.H., Jobin, C., and Ting, J.P. (2010) The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J. Exp. Med. 207, 1045-1056.
67. Hirota, S.A., Ng, J., Lueng, A., Khajah, M., Parhar, K., Li, Y., Lam, V., Potentier, M.S., Ng, K., Bawa, M., McCafferty, D.M., Rioux, K.P., Ghosh, S., Xavier, R.J., Colgan, S.P., Tschopp, J., Muruve, D., MacDonald, J.A., and Beck, P.L. (2011) NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis. Inflamm. Bowel Dis. 17, 1359-1372.
68. Dupaul-Chicoine, J., Yeretssian, G., Doiron, K., Bergstrom, K.S., McIntire, C.R., LeBlanc, P.M., Meunier, C., Turbide, C., Gros, P., Beauchemin, N., Vallance, B.A., and Saleh, M. (2010) Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases. Immunity 32, 367-378.
69. Bauer, C., Duewell, P., Mayer, C., Lehr, H.A., Fitzgerald, K.A., Dauer, M., Tschopp, J., Endres, S., Latz, E., and Schnurr, M. (2010) Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome. Gut 59, 1192-1199.
70. Wehkamp, J., Harder, J., Weichenthal, M., Schwab, M., Schaffeler, E., Schlee, M., Herrlinger, K.R., Stallmach, A., Noack, F., Fritz, P., Schroder, J.M., Bevins, C.L., Fellermann, K., and Stange, E.F. (2004) NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut 53, 1658-1664.
71. Okamura, H., Tsutsi, H., Komatsu, T., Yutsudo, M., Hakura, A., Tanimoto, T., Torigoe, K., Okura, T., Nukada, Y., Hattori, K., et al. (1995) Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378, 88-91.
72. Nava, P., Koch, S., Laukoetter, M.G., Lee, W.Y., Kolegraff, K., Capaldo, C.T., Beeman, N., Addis, C., Gerner-Smidt, K., Neumaier, I., Skerra, A., Li, L., Parkos, C.A., and Nusrat, A. (2010) Interferon-gamma regulates intestinal epithelial homeostasis through converging beta-catenin signaling pathways. Immunity 32, 392-402.
73. McGettrick, A.F. and O'Neill, L.A. (2004) The expanding family of MyD88-like adaptors in Toll-like receptor signal transduction. Mol. Immunol. 41, 577-582.
74. Araki, A., Kanai, T., Ishikura, T., Makita, S., Uraushihara, K., Iiyama, R., Totsuka, T., Takeda, K., Akira, S., and Watanabe, M. (2005) MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis. J. Gastroenterol. 40, 16-23.
75. Cario, E., Gerken, G., and Podolsky, D.K. (2007) Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 132, 1359-1374.
76. Fukata, M., Michelsen, K.S., Eri, R., Thomas, L.S., Hu, B., Lukasek, K., Nast, C.C., Lechago, J., Xu, R., Naiki, Y., Soliman, A., Arditi, M., and Abreu, M.T. (2005) Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 288, G1055-1065.
77. Watanabe, T., Asano, N., Murray, P.J., Ozato, K., Tailor, P., Fuss, I.J., Kitani, A., and Strober, W. (2008) Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis. J. Clin. Invest. 118, 545-559.
78. Petnicki-Ocwieja, T., Hrncir, T., Liu, Y.J., Biswas, A., Hudcovic, T., Tlaskalova-Hogenova, H., and Kobayashi, K.S. (2009) Nod2 is required for the regulation of commensal microbiota in the intestine. Proc. Natl. Acad. Sci. U. S. A. 106, 15813-15818.
79. Kosovac, K., Brenmoehl, J., Holler, E., Falk, W., Schoelmerich, J., Hausmann, M., and Rogler, G. (2010) Association of the NOD2 genotype with bacterial translocation via altered cell-cell contacts in Crohn's disease patients. Inflamm. Bowel Dis. 16, 1311-1321.
80. Loftus, E.V., Jr. (2004) Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 126, 1504-1517.
81. Long, M.D., Crandall, W.V., Leibowitz, I.H., Duffy, L., Del Rosario, F., Kim, S.C., Integlia, M.J., Berman, J., Grunow, J., Colletti, R.B., Schoen, B.T., Patel, A.S., Baron, H., Israel, E., Russell, G., Ali, S., Herfarth, H.H., Martin, C., and Kappelman, M.D. (2010) Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease. Inflamm. Bowel Dis. [Epub ahead of print]